TECH - BIO-TECHNE Corp

57.85
0.860   1.487%

Share volume: 2,194,448
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.44%

PREVIOUS CLOSE
CHG
CHG%
$56.99
0.86
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
40%
Profitability 24%
Dept financing 40%
Liquidity 37%
Performance 56%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0.05%
1 Month
-12.16%
3 Months
-6.21%
6 Months
6.32%
1 Year
-6.99%
2 Year
-21.19%
Key data
Stock price
$57.85
P/E Ratio 
112.98
DAY RANGE
$56.92 - $58.07
EPS 
$0.53
52 WEEK RANGE
$46.01 - $72.16
52 WEEK CHANGE
-$8.74
MARKET CAP 
9.163 B
YIELD 
0.54%
SHARES OUTSTANDING 
156.453 M
DIVIDEND
$0.08
EX-DIVIDEND DATE
02-13-2026
NEXT EARNINGS DATE
08-06-2025
BETA 
1.02
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$2,323,384
AVERAGE 30 VOLUME 
$2,553,908
Company detail
CEO: Charles R. Kummeth
Region: US
Website: bio-techne.com
Employees: 3,000
IPO year: 1992
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing

Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services. Protein Sciences segment provides biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy. Diagnostics and Genomics segment provides diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market.

Recent news